Related Experiment Videos
A novel growth stimulating activity from BRL-3A cell conditioned medium
1Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
Cell Proliferation
|June 1, 1997
Summary
Researchers identified a novel growth factor in BRL-3A cell conditioned medium that stimulates R- cells lacking insulin-like growth factor 1 receptors (IGF-IRs). This factor promotes cell growth and DNA synthesis, suggesting a new pathway for cell proliferation.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- The R- cell line, derived from mouse embryos, has a homozygous disruption of insulin-like growth factor 1 receptor (IGF-IR) genes.
- R- cells exhibit limited growth in serum-free medium (SFM) even with known growth factors, but can grow in serum.
- This suggests the presence of an unidentified growth factor in serum that supports cell growth independently of IGF-IR signaling.
Purpose of the Study:
- To identify the unknown growth factor present in serum that promotes cell proliferation in R- cells.
- To screen conditioned media from various cell lines for growth-stimulating activity on R- cells.
Main Methods:
- Utilized R- cells as a model system to screen for growth-promoting activity.
- Assayed conditioned media from different cell lines for their ability to stimulate DNA synthesis and cell proliferation in R- cells.
- Characterized the activity using ultrafiltration, heat denaturation, and proteinase K sensitivity.
Main Results:
- BRL-3A cell line conditioned medium exhibited significant growth and DNA synthesis stimulating activity on R- cells.
- The activity was found to be concentration-dependent.
- The active component is heat-labile, proteinase K-sensitive, and larger than 10 kDa.
Conclusions:
- A novel polypeptide with growth-promoting activity has been identified in BRL-3A cell conditioned medium.
- This factor stimulates proliferation in cells lacking functional IGF-IRs, indicating a new growth pathway.
- Further characterization of this novel growth factor is ongoing.